LipoCoat is specialized in developing infection control solutions for the healthcare industry, with a focus on medical devices. The company is active in development programs with medtech multinationals that want to increase the safety of their medical devices. LipoCoat’s unique bio-inspired and non-toxic coatings prevent adhesion of microbes, thus reducing infection risks. Just five nanometers thick, the revolutionary coating technology is designed to make any biomaterial surface non-thrombogenic, non-fouling and resistant to the surface-pollution of micro-organisms and proteins.
Improving the quality and safety of medical devices
Contaminated medical devices are one of the leading causes of Healthcare Associated Infections (HAIs), which affects millions of patients and costs tens of billions in healthcare expenditure. Despite advancements in prevention guidelines, these evidence-based strategies still do not offer a full and sustainable working solution.
The current Covid-19 pandemic shows the importance of scientific progression in regard to infection control. LipoCoat has seen a very promising reduction in bacterial adhesion on contact lenses and catheters, and is aiming to launch LipoCoat-enabled contact lenses this year. In a few years’ time, the company expects its first coated catheters to enter the market.
